Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1233 - 1240 of 11616 results
My Health, My Data! Washington State Enacts Broad Health Data Privacy Protection Law
May 24, 2023| Blog| Viewpoint
Intellectual Property for the Metaverse
May 24, 2023| Blog| Viewpoint
9 Things For Companies To Consider Before Using AI Tools
May 23, 2023| News
Health Care Pro Departs Jones Day For Mintz In San Francisco
May 23, 2023| News
Pillsbury White Collar Pro Jumps To Mintz In San Francisco
May 22, 2023| News
New York City Council Passes Prohibition on “Height” and “Weight” Discrimination
May 19, 2023| Blog| Viewpoint
No More Mr. Nice BI: Reg BI Violation Leads to Expulsion for FINRA Member Firm
May 19, 2023| Blog| Viewpoint
With More Than 400 Clients In San Francisco, Mintz Prioritizes Office Growth
May 19, 2023| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.